A method for generating vascular progenitor cells from pluripotent stem cells through CHIR and WNT signaling modulation followed by magnetic purification.

Patentradars sammanfattning

This biotech process describes a differentiation protocol for deriving vascular progenitor cells (VPCs) from pluripotent stem cells (PSCs) over multiple days (D2-D8). The method employs CHIR (Wnt agonist) and WNT C59 (Wnt inhibitor) signaling pathway modulation during sequential differentiation stages, with magnetic-activated cell sorting (MACS) for enrichment of target cells and flow cytometry-based characterization using markers like TRA 1-60 to identify undifferentiated stem cells and track differentiation efficiency.

AI-genererad och redaktionellt processad.